Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational medication mezagitamab can effectively boost platelet ... Medscape: Upfront Therapy for ITP in Kids: New Drug a Game Changer? Children with newly diagnosed immune thrombocytopenia (ITP) treated with eltrombopag as a frontline therapy show significantly improved platelet responses and other outcomes compared with the standard ...
SAN DIEGO -- Treatment with an investigational oral inhibitor of Bruton's tyrosine kinase (BTK) was safe and boosted platelet counts in heavily pretreated patients with immune thrombocytopenia (ITP), ... The American Journal of Managed Care: LUNA 3 Trial Evaluation: Understanding BTK Inhibition in ITP Management ITP does not increase the risk of getting or having severe COVID-19. COVID-19 infection can cause thrombocytopenia, even in those without ITP history. ITP may develop as a rare side effect of the ...
itp medication, The American Journal of Managed Care: Diagnostic and Patient Education Strategies in ITP A panelist discusses how ITP diagnosis remains one of exclusion requiring thorough testing to rule out other causes of thrombocytopenia, followed by patient education about autoimmune diseases and ...
